ParaPRO

Focus: ParaPRO is a biotechnology company focused on antiparasitic therapies for infestations including head lice and scabies, based in Carmel, Indiana. The company operates in the niche infectious diseases segment with a pipeline of topical formulations.

Infectious Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About ParaPRO

AI assessmentNot Hiring

No open roles listed right now. Follow ParaPRO to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

4 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Spinosad

Head Lice

Phase 1

Clinical Trials (1)

NCT00591331Phototoxicity Potential of NatrOVA Creme Rinse - 1%

Phase 1

Help build intelligence for ParaPRO

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused pipeline with 11 active clinical trials across spinosad and NatrOVA programs targeting high-prevalence conditions
Opportunity to contribute to rare disease/neglected indication development in a specialized therapeutic area
Early-stage company structure may offer broader cross-functional exposure and faster decision-making

Watch Out For

Minimal hiring activity (only 1 active role in Sales) suggests company is in conservation mode or early growth phase
No disclosed financial data, revenue, or funding history raises questions about capitalization and runway stability
Lack of published research output (0 publications) and absence of recent news suggests limited visibility and momentum in biotech ecosystem

Generated by Claude from ParaPRO's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NatrOVA Creme Rinse - 1%

Head Lice

Phase 1

Clinical Trials (1)

NCT00605956NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers

Phase 1

NatrOVA Creme Rinse

Pediculosis Capitis (Head Lice)

Phase 1

Clinical Trials (1)

NCT00410709A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age

Phase 1